ANTI-PHOSPHOLIPASE-D4-ANTIKÖRPER

European patent · EP2809683 · In force

Register entry

Publication number
EP2809683
Application number
EP13705843
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 31, 2013
Published
Dec 10, 2014
Granted
Oct 3, 2018
Protection ends at the latest
Jan 30, 2033
Next annual fee due
Jan 31, 2027
IPC classes
C07K 16/40 (2006.01)
C07K 16/28 (2006.01)
Priority
JP 2012018266 31.01.2012
PCT application
PCT/JP2013/052781 31.01.2013
PCT publication
WO2013/115410 08.08.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Oct 20, 2018

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 20.10.2018

  6. Oct 3, 2018

    Granted

    Published in Swissreg on 03.10.2018

Parties

Holder

SBI Biotech Co., Ltd.

1-6-1, Roppongi, Minato-ku Tokyo 106-6018, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

ENDO, Mayuki

Tokyo 106-6018, JP

ISHIDA, Koji

Tokyo 106-6018, JP

CHO, Minkwon

Tokyo 106-6018, JP

YAMAZAKI, Tomohide

Tokyo 106-6018, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.